Filtered By:
Condition: Depression
Therapy: Pain Management
Countries: France Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
Conclusions: Patients with spasticity can expect a characteristic profile of BoNT-A effects, namely time lag to onset and peak effect followed by a gradual decline in the symptomatic benefits. Symptom re-emergence is common and has significant impact on quality of life. Greater patient/clinician awareness of this therapeutic profile should lead to better level of overall satisfaction with treatment, informed therapeutic discussions and treatment schedule planning.
Source: Frontiers in Neurology - May 6, 2020 Category: Neurology Source Type: research
